{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:48:07Z","timestamp":1766087287349},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n            <jats:title>Background and aim<\/jats:title>\n            <jats:p>No comprehensive and prospective data are available for concurrent extrahepatic autoimmune disorders (CEAIDs) in children with autoimmune liver disease (AILD). The aim of this study was to evaluate CEAIDs in AILD and their effect on AILD outcome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and methods<\/jats:title>\n            <jats:p>Enrolled AILD and CEAIDs children were diagnosed on the basis of simplified and standard diagnostic criteria, respectively. The clinicopathological profile, treatment response, and outcome were compared between AILD with CEAIDs (group A) and AILD without CEAIDs (group B).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In 62 AILD children, CEAIDs were found in 42% (<jats:italic toggle=\"yes\">n<\/jats:italic>=26) [vitiligo (42%), celiac disease (CD) (15%), potential CD (15%), autoimmune hemolytic anemia (AIHA) (15%)]. CEAIDs were asymptomatic in 75%. Single CEAID was found in 81% (21\/26) and multiple CEAID was found in 19% (5\/26). Significantly less biochemical remission (46.1 vs. 74.2%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.03), more treatment failure (23 vs. 3.2%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.04), and higher mortality (15.3 vs. 3.2%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.04) were encountered in group A compared with group B. On multivariate analysis (<jats:italic toggle=\"yes\">n<\/jats:italic>=57), less biochemical remission in vitiligo (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.04); more treatment failure in AIHA (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.004) and vitiligo (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.04); and high mortality in AIHA (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.02) subgroups were reported. CD treatment has good impact on AILD outcome. All cases of diabetes mellitus in AILD were steroid-induced rather than because of autoimmunity (absence of antibody against tyrosine phosphatase and glutamic acid decarboxylase and elevated C-peptide).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>All AILD children should be screened for CEAIDs as the majority are asymptomatic. The AILD outcome was favorable in CD, but poor in vitiligo and AIHA. We suggest the incorporation of CEAIDs in a pediatric AILD scoring system.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/meg.0000000000001122","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T13:45:59Z","timestamp":1523367959000},"page":"910-917","source":"Crossref","is-referenced-by-count":4,"title":["Concurrent extrahepatic autoimmune disorders: unexplored dimension of autoimmune liver disease in children"],"prefix":"10.1097","volume":"30","author":[{"given":"Vikas","family":"Jain","sequence":"first","affiliation":[{"name":"Pediatric Gastroenterology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surender K.","family":"Yachha","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eesh","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moinak S.","family":"Sarma","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anshu","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/MPG.0b013e31828b1dfa","article-title":"Celiac disease associated autoimmune hepatitis in childhood: long-term response to treatment","volume":"56","author":"Nastasio","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R3-20230916","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/MEG.0000000000000424","article-title":"Autoimmune liver disease and concomitant extrahepatic autoimmune disease","volume":"27","author":"Muratori","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R4-20230916","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MCG.0b013e3181c74e0d","article-title":"Concurrent autoimmune diseases in patients with autoimmune hepatitis","volume":"44","author":"Teufel","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jpeds.2013.12.008","article-title":"Outcome after discontinuation of immunosuppression in children with autoimmune hepatitis: a population-based study","volume":"164","author":"Deneau","year":"2014","journal-title":"J Pediatr"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/MPG.0b013e31828dc5c5","article-title":"Pediatric celiac disease, cryptogenic hypertransaminasemia and autoimmune hepatitis","volume":"56","author":"Vajro","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cgh.2007.12.002","article-title":"Autoimmune liver disease associated with celiac disease in childhood: a multicenter study","volume":"6","author":"Caprai","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","article-title":"European Society for Pediatric Gastroenterology and Nutrition guidelines for the diagnosis of coeliac disease","volume":"54","author":"Husby","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R9-20230916","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cgh.2011.11.030","article-title":"Validation and modification of simplified diagnostic criteria for autoimmune hepatitis in children","volume":"10","author":"Mileti","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R10-20230916","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients","volume":"55","author":"Zachou","year":"2011","journal-title":"J Hepatol"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1097\/MEG.0000000000000975","article-title":"Autoimmune acute liver failure and seronegative autoimmune liver disease in children: are they different from classical disease","volume":"29","author":"Jain","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl 12","key":"R13-20230916","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1399-5448.2009.00568.x","article-title":"Definition, epidemiology and classification of diabetes in children and adolescents","volume":"10","author":"Craig","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/clinchem\/45.7.1087","article-title":"Pediatric reference intervals for serum thyroxine, triiodothyronine, thyrotropin and free thyroxine","volume":"45","author":"Zurakowski","year":"1999","journal-title":"Clin Chem"},{"key":"R15-20230916","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","article-title":"The histopathology of celiac disease: time for a standardized report scheme for pathologists","volume":"11","author":"Oberhuber","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3949\/ccjm.78a.10180","article-title":"Glucocorticoid-induced diabetes and adrenal suppression: how to detect and manage them","volume":"78","author":"Lansang","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1515\/JPEM.2003.16.8.1111","article-title":"Autoimmune thyroid dysfunction in children with type-I diabetes mellitus: screening guidelines based on a retrospective analysis","volume":"16","author":"Bilimoria","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R18-20230916","first-page":"9","article-title":"Update on autoimmune polyendocrine syndromes (APS)","volume":"74","author":"Betterle","year":"2003","journal-title":"Acta Biomed"},{"key":"R19-20230916","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1371\/journal.pmed.0030289","article-title":"Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type I","volume":"3","author":"Meager","year":"2006","journal-title":"PLoS Med"},{"key":"R21-20230916","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/000456328101800301","article-title":"Circulating C peptide: measurement and clinical application","volume":"18","author":"Ashby","year":"1981","journal-title":"Ann Clin Biochem"},{"key":"R22-20230916","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0925-5710(98)00087-5","article-title":"Direct antiglobulin test negative autoimmune hemolytic anemia associated with autoimmune hepatitis","volume":"68","author":"Kondo","year":"1998","journal-title":"Int J Hematol"},{"key":"R23-20230916","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/MPG.0000000000000270","article-title":"Giant cell hepatitis with autoimmune hemolyticanemia in children: proposal for therapeutic approach","volume":"58","author":"Bakula","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R24-20230916","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0625.2010.01181.x","article-title":"Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo","volume":"20","author":"Kemp","year":"2011","journal-title":"Exp Dermatol"},{"key":"R25-20230916","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.autrev.2015.12.006","article-title":"Vitiligo: pathogenesis, clinical variants and treatment approaches","volume":"15","author":"Iannella","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R26-20230916","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1365-4362.1999.00623.x","article-title":"The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients","volume":"38","author":"Kim","year":"1999","journal-title":"Int J Dermatol"},{"key":"R27-20230916","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","article-title":"NALP1 in vitiligo-associated multiple autoimmune diseases","volume":"356","author":"Jin","year":"2007","journal-title":"N Engl J Med"},{"key":"R28-20230916","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00042737-201808000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T15:31:02Z","timestamp":1694878262000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042737-201808000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000001122","relation":{},"ISSN":["0954-691X"],"issn-type":[{"value":"0954-691X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}